The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study
This qualitative interview study (n=14) of the use of ayahuasca in those with severe physical illnesses (SPI) identified several psychological mechanisms that were being deployed (introspection, self-analysis, autobiographical memories, perspective changes, and more).
Authors
- Luiz Tófoli
- Dimitri Daldegan-Bueno
- Lucas Maia
Published
Abstract
Diseases that threaten life raise existential questions that can be a source of psychological distress. Studies with psychedelics demonstrate therapeutic effects for anxiety and depression associated with life-threatening illnesses. Ayahuasca has been proposed as a possible therapeutic agent in the treatment of psychiatric disorders. Preliminary studies suggest that ayahuasca could promote therapeutic effects for people with physical illnesses. The aim of this study was to explore how the ritual use of ayahuasca during the treatment of severe physical illnesses (SPI) may influence the way people understand and relate to their illness, using qualitative methods to assess the participants' perspectives. Participants who consumed ayahuasca ritualistically during the period of treatment for SPI were purposely chosen. Data were obtained through semi-structured interviews. A thematic analysis was performed with 14 individuals. The ritual experience with ayahuasca acted on the participants' illness understanding through multiple psychological mechanisms, including introspection, self-analysis, emotional processing and catharsis, recall of autobiographical memories subjectively related to illness origin, illness resignification, and perspective changes. This study suggests that the experience with ayahuasca may facilitate illness acceptance through an influence on the meanings of the illness, life, and death. These changes may favor a more balanced relationship with illness and treatment.
Research Summary of 'The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study'
Introduction
Severe physical illnesses (SPI) such as cancer and other life‑threatening or disabling conditions often provoke intense psychological distress, including high rates of depression and anxiety. Previous trials with classic serotonergic psychedelics (for example, LSD and psilocybin) have shown benefits for anxiety and depression in the context of life‑threatening illness, and a growing body of work has suggested therapeutic potential for ayahuasca, a traditional Amazonian brew whose active constituents include DMT and β‑carbolines. Despite increasing use of ayahuasca in Brazil and preliminary reports that ritual ayahuasca experiences may improve coping and well‑being in people with physical illnesses, the psychological mechanisms by which ritual use might influence patients' understanding of and relationship to their illness remain poorly articulated. This study, conducted by Oliveira and colleagues, aimed to explore how ritual ayahuasca use during the treatment of SPI may shape the way people understand and relate to their illness. The investigators used qualitative methods to elicit participants' subjective accounts, with the stated goal of identifying psychological processes—such as changes in meaning, emotional processing, or outlook on life and death—that could help explain reported therapeutic effects and inform further clinical research in this area.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Maia, L. O., Daldegan-Bueno, D., & Tófoli, L. F. (2021). The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study. Journal of Psychoactive Drugs, 53(3), 272-282. https://doi.org/10.1080/02791072.2020.1854399
References (25)
Papers cited by this study that are also in Blossom
Argento, E., Capler, R., Thomas, G. et al. · Drug and Alcohol Review (2019)
Barbosa, P., Tófoli, L.F., Bogenschutz, M. P. et al. · Frontiers in Psychiatry (2018)
Barker, S. · Frontiers in Neuroscience (2018)
Dos Santos, R. G., Osório, F. L., Crippa, J. A. et al. · brazilian Journal of Psychiatry (2016)
Dyck, E. · Journal of Psychoactive Drugs (2019)
Franquesa, A., Sainz-Cort, A., Gandy, S. et al. · Psychiatry Research (2018)
Galvão-Coelho, N. L., de Menezes Galvão, A. C., de Almeida, R. N. et al. · Journal of Psychopharmacology (2020)
Kirchner, K. · Journal of Psychopharmacology (2014)
Griffiths, R. R., Johnson, M. W. · Journal of Psychopharmacology (2016)
Horák, M., Hasíková, L., Verter, N. et al. · Journal of Psychoactive Drugs (2018)
Show all 25 referencesShow fewer
Ross, S., Malone, T. C., Mennenga, S. E. et al. · Frontiers in Pharmacology (2018)
Moreton, S. G., Szalla, L., Menzies, R. E. et al. · Psychopharmacology (2019)
Ona, G., Kohek, M., Massaguer, T. et al. · Journal of Psychoactive Drugs (2019)
Palhano-Fontes, F., Barreto, D., Onias, H. et al. · Psychological Medicine (2018)
Reiche, S., Hermle, L., Gutwinski, S. et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018)
Renelli, M., Fletcher, J., Tupper, K. W. et al. · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2018)
Riba, J., Valle, M., Urbano, G. et al. · Journal of Pharmacology and Experimental Therapeutics (2003)
Ross, S., Bossis, A. P., Guss, J. et al. · Journal of Psychopharmacology (2016)
Schenberg, E. E. · Sage Open Medicine (2013)
Schenberg, E. E., Alexandre, J. F. M., Filev, R. et al. · PLOS ONE (2015)
Soler, J., Elices, M., Franquesa, A. et al. · Psychopharmacology (2015)
Elices, M., Soler, J., Domínguez-Clavé, E. et al. · Frontiers in Pharmacology (2018)
Thomas, G., Lucas, P., Rielle Capler, N. et al. · Current Drug Abuse Reviews (2013)
Trichter, S., Klimo, J., Krippner, S. · Journal of Psychoactive Drugs (2009)
Uthaug, M. V., Van Oorsouw, &. K., Kuypers, &. K. P. C. et al. · Psychopharmacology (2018)
Cited By (4)
Papers in Blossom that reference this study
Perkins, D., Ruffell, S. G. D., day, K. et al. · Frontiers in Neuroscience (2023)
Kohek, M., Ona, G., Dos Santos, R. G. et al. · Journal of Psychoactive Drugs (2022)
Soares, C. M., Leite, A., Pinto, M. · Journal of Psychoactive Drugs (2022)
Maia, L. O., Massarentti, C. M., Tófoli, L.F. · Psychopharmacology (2022)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.